MFECP1 antibody-enzyme conjugate and ZD2767P prodrug

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMFECP1 antibody-enzyme conjugate and ZD2767P prodrug
Drug Alias NameMFE-CP1-targeted ZD-2767-P ADEPT (colorectal/CEA tumors)MFE-CP1ZD-2767-P
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research UK
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A